Evaluation of domino liver transplantations in Germany

Transplant International

Volumn 26, Issue 7, 2013, Pages 715-723

  Bolte, Fabian Johannes ^a   Schmidt, Hartmut H J ^a   Becker, Thomas ^b   Braun, Felix ^b   Pascher, Andreas ^c   Klempnauer, Jürgen ^d   Schmidt, Jan ^e   Nadalin, Silvio ^f   Otto, Gerd ^g   Barreiros, Ana Paula ^g  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d HANNOVER MEDICAL SCHOOL   (Germany)

^e UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^f UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^g UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

de novo amyloidosis; familial amyloidotic polyneuropathy; follow up; post transplant diabetes mellitus; survival

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; FAMILIAL AMYLOIDOSIS; FEMALE; FOLLOW UP; GERMANY; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; AGED; AMYLOID NEUROPATHIES, FAMILIAL; AMYLOIDOSIS; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES;

EID: 84879008608     PISSN: 09340874     EISSN: 14322277     Source Type: Journal    
DOI: 10.1111/tri.12110     Document Type: Article

References (53)

1. Connors LH, Lim A, Prokaeva T, Roskens VA, Costello CE,. Tabulation of human transthyretin (TTR) variants, 2003. Amyloid 2003; 10: 160.
2. Benson M, Kincaid J,. The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 2007; 36: 411.
3. Ando Y, Nakamura M, Araki S,. Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 2005; 62: 1057.
4. Andrade C,. A peculiar form of peripheral neuropathy; familiar atypical generalized amyloidosis with special involvement of the peripheral nerves. Brain 1952; 75: 408.
5. Sousa A, Andersson R, Drugge U, Holmgren G, Sandgren O,. Familial amyloidotic polyneuropathy in Sweden: geographical distribution, age of onset, and prevalence. Hum Hered 1993; 43: 288.
6. Herlenius G, Wilczek HE, Larsson M, Ericzon BG,. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the Familial Amyloidotic Polyneuropathy World Transplant Registry. Transplantation 2004; 77: 64.
7. Holmgren G, Ericzon BG, Groth CG, et al,. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet 1993; 341: 1113.
8. Parrilla P, Ramirez P, Bueno FS, et al,. Clinical improvement after liver transplantation for type I familial amyloid polyneuropathy. Br J Surg 1995; 82: 825.
9. Pomfret EA, Lewis WD, Jenkins RL, et al,. Effect of orthotopic liver transplantation on the progression of familial amyloidotic polyneuropathy. Transplantation 1998; 65: 918.
10. Suhr OB, Herlenius G, Friman S, Ericzon BG,. Liver transplantation for hereditary transthyretin amyloidosis. Liver Transpl 2000; 6: 263.
11. Adams D, Slama M, Samuel D,. Liver transplantation for familial amyloid polyneuropathy. Presse Med 2010; 39: 17.
12. Holmgren G, Steen L, Ekstedt J, et al,. Biochemical effect of liver transplantation in two Swedish patients with familial amyloidotic polyneuropathy (FAP-met30). Clin Genet 1991; 40: 242.
13. Ericzon BG, Larsson M, Wilczek HE,. Domino liver transplantation: risks and benefits. Transplant Proc 2008; 40: 1130.
14. Ericzon BG, Larsson M, Herlenius G, Wilczek HE,. Report from the Familial Amyloidotic Polyneuropathy World Transplant Registry (FAPWTR) and the Domino Liver Transplant Registry (DLTR). Amyloid 2003; 10: 67.
15. Samuel D, Adams D,. Domino liver transplantation from familial amyloidotic polyneuropathy donors: how close is the damocles sword to the recipient? Transpl Int 2007; 20: 921.
16. Tojo K, Sekijima Y, Machida K, Tsuchiya A, Yazaki M, Ikeda S,. Amyloidogenic transthyretin Val30Met homozygote showing unusually early-onset familial amyloid polyneuropathy. Muscle Nerve 2008; 37: 796.
17. Furtado A, Tome L, Oliveira FJ, Furtado E, Viana J, Perdigoto R,. Sequential liver transplantation. Transplant Proc 1997; 29: 467.
18. Furtado A,. Domino liver transplantation using FAP grafts. HUC experience-hopes and realities. Amyloid 2003; 10: 84.
19. Schmidt HH, Nashan B, Propsting MJ, et al,. Familial Amyloidotic Polyneuropathy: domino liver transplantation. J Hepatol 1999; 30: 293.
20. Dept of Transplantation Surgery, Karolinska University Hospital Huddinge. Familial Amyloidotic Polyneuropathy World Transplant Registry and Domino Liver Transplant Registry. 2011. Available at: http://www.fapwtr.org/ram-domino.htm (accessed 02 March 2013).
21. Information about how the Model for End-Stage Liver Disease (MELD) and Pediatric End-Stage Liver Disease (PELD), numerical scales that are currently used for liver allocation. MELD/PELD Calculator Q & A. 2009. Available at: http://www.unos.org/ docs/MELD-PELD-Calculator-Documentation.pdf (accessed 17 July 2011).
22. Mazzaferro V, Regalia E, Doci R, et al,. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693.
23. Barreiros AP, Geber C, Birklein F, Galle PR, Otto G,. Clinical symptomatic de novo systemic transthyretin amyloidosis 9 years after domino liver transplantation. Liver Transpl 2010; 16: 109.
24. Stangou AJ, Heaton ND, Hawkins PN,. Transmission of systemic transthyretin amyloidosis by means of domino liver transplantation. N Engl J Med 2005; 352: 2356. (Pubitemid 40740565)
25. Goto T, Yamashita T, Ueda M, et al,. Iatrogenic amyloid neuropathy in a Japanese patient after sequential liver transplantation. Am J Transplant 2006; 6: 2512.
26. Castaing D, Salloum C, Azoulay D, et al,. Adult liver transplantation: the Paul Brousse experience. Clin Transpl 2007; 145.
27. Adams D, Lacroix C, Antonini T, et al,. Short Communications. Risk of developing de novo amyloid deposits and induced polyneuropathy in FAP domino liver recipients. Eur J Neurol 2009; 16: 16.
28. Llado L, Baliellas C, Casasnovas C, et al,. Risk of transmission of systemic transthyretin amyloidosis after domino liver transplantation. Liver Transpl 2010; 16: 1386.
29. Conceicao I, Evangelista T, Castro J, et al,. Acquired amyloid neuropathy in a Portuguese patient after domino liver transplantation. Muscle Nerve 2010; 42: 836.
30. Obayashi K, Yamashita T, Tasaki M, et al,. Amyloid neuropathy in a younger domino liver transplanted recipient. Muscle Nerve 2011; 43: 449.
31. Wilczek HE, Larsson M, Yamamoto S, Ericzon B,. Domino liver transplantation. J Hepatobiliary Pancreat Surg 2008; 15: 139.
32. Wolff M, Kalff JC, Schwarz NT, et al,. Liver transplantation in Germany. Zentralbl Chir 2003; 128: 831.
33. Mazzaferro V, Llovet JM, Miceli R, et al,. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncol 2009; 10: 35.
34. Bispo M, Marcelino P, Marques HP, et al,. Domino versus deceased donor liver transplantation: Association with early graft function and perioperative bleeding. Liver Transpl 2011; 17: 270.
35. Dyck PJ,. Detection, characterization, and staging of polyneuropathy: assessed in diabetics. Muscle Nerve 1988; 11: 21.
36. Dyck PJ, Kratz KM, Lehman KA, et al,. The Rochester Diabetic Neuropathy Study: design, criteria for types of neuropathy, selection bias, and reproducibility of neuropathic tests. Neurology 1991; 41: 799.
37. Feldman EL, Shefner JM, Dashe JF,. Clinical manifestations and diagnosis of diabetic polyneuropathy. 2010. Available at: http://www.uptodate.com/ contents/clinical-manifestations-and-diagnosis-of-diabetic-polyneuropathy? source=search-result&selected Title=1%7E102 (accessed 17 July 2011).
38. Young MJ, Boulton AJ, MacLeod AF, Williams DR, Sonksen PH,. A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia 1993; 36: 150.
39. Bril V,. NIS-LL: the primary measurement scale for clinical trial endpoints in diabetic peripheral neuropathy. Eur Neurol 1999; 41 (Suppl. 1): 8.
40. Dyck P,. Quantitating severity of neuropathy. In:, Dyck P, Thomas P, Griffin J, Low P, Poduslo J, eds. Peripheral Neuropathy. Philadelphia: Saunders, 1993: 685.
41. Dyck PJ, O'Brien PC, Kosanke JL, Gillen DA, Karnes JL,. A 4, 2, and 1 stepping algorithm for quick and accurate estimation of cutaneous sensation threshold. Neurology 1993; 43: 1508.
42. Yamamoto S, Wilczek HE, Iwata T, et al,. Long-term consequences of domino liver transplantation using familial amyloidotic polyneuropathy grafts. Transpl Int 2007; 20: 926.
43. Ayres RC, Dousset B, Wixon S, Buckels JA, McMaster P, Mayer AD,. Peripheral neurotoxicity with tacrolimus. Lancet 1994; 343: 862.
44. The U.S Multicenter FK506 Liver Study Group. A comparison of tacrolimus (FK 506) and cyclosporine for immunosuppression in liver transplantation. N Engl J Med 1994; 331: 1110.
45. Bittencourt PL, Couto CA, Leitao RM, et al,. No evidence of de novo amyloidosis in recipients of domino liver transplantation: 12 to 40 (mean 24) month follow-up. Amyloid 2002; 9: 194.
46. Takei Y, Gono T, Yazaki M, et al,. Transthyretin-derived amyloid deposition on the gastric mucosa in domino recipients of familial amyloid polyneuropathy liver. Liver Transpl 2007; 13: 215.
47. Klein AL, Hatle LK, Burstow DJ, et al,. Comprehensive Doppler assessment of right ventricular diastolic function in cardiac amyloidosis. J Am Coll Cardiol 1990; 15: 99.
48. Barreiros AP, Post F, Hoppe-Lotichius M, et al,. Liver transplantation and combined liver-heart transplantation in patients with familial amyloid polyneuropathy: a single-center experience. Liver Transpl 2010; 16: 314.
49. Di Bella G, Minutoli F, Mazzeo A, et al,. MRI of cardiac involvement in transthyretin familial amyloid polyneuropathy. AJR Am J Roentgenol 2010; 195: W394.
50. Bigam DL, Pennington JJ, Carpentier A, et al,. Hepatitis C-related cirrhosis: a predictor of diabetes after liver transplantation. Hepatology 2000; 32: 87.
51. Delgado-Borrego A, Liu YS, Jordan SH, et al,. Prospective study of liver transplant recipients with HCV infection: evidence for a causal relationship between HCV and insulin resistance. Liver Transpl 2008; 14: 193.
52. Laish I, Braun M, Mor E, Sulkes J, Harif Y, Ben Ari Z,. Metabolic syndrome in liver transplant recipients: prevalence, risk factors, and association with cardiovascular events. Liver Transpl 2011; 17: 15.
53. Coelho T, Maia LF, Martins da Silva A, et al,. Tafamidis for transthyretin familial amyloid polyneuropathy: a randomized, controlled trial. Neurology 2012; 79: 785.